Learn how we advance public health globally by researching the frequency, distribution, and causes of human disease, and shaping health policies and practices.
Bill Hanage discusses the implications of a new FDA policy that will limit the COVID-19 vaccine to people over age 65 and those with certain medical conditions.
In the wake of the cancellation of federal grant funding for more than 130 researchers at Harvard Chan School, faculty, staff, and students are speaking out about the havoc enveloping the School.
Fallout in the public health arena from recent federal government actions—health programs dismantled, health agencies gutted, research grants cancelled, and universities penalized—were among the topics discussed at the 9th Cutter Symposium.
Decisions made by the current U.S. administration could lead to more traumatic stress-related mental and physical health issues across the world, as well as disrupt research and practice in the field of traumatic stress, according to Karestan Koenen and colleagues.
Joy Shi is an epidemiologist and assistant professor at the Mongan Institute, Massachusetts General Hospital and CAUSALab, Department of Epidemiology, Harvard T.H. Chan School of Public Health. She is interested…
Some researchers are welcoming a Trump administration executive order calling for tighter policies on so-called gain-of-function research—experiments that could make pathogens more dangerous. But they are also expressing concern about what exactly the order would mean.
With a mission to improve health in the Philippines, Vicente “Vito” Puyat, SM ’25, has learned that, while data is critical for public health, it’s part of a bigger picture.
Teaming up with grassroots organizers in India, Caroline Buckee, Satchit Balsari and colleagues are collecting data to help workers adapt to dangerous spikes in heat.
